Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients

Author(s):
Staveren, M.C. van; Opdam, F.; Guchelaar, H.J. (0000-0002-7085-1383); Kuilenburg, A.B.P. van; Maring, J.G.; Gelderblom, H.
Published
2015
Publication type
Article / Letter to editor
Dihydropyrimidine dehydrogenaseUracilColorectal cancer5-FluorouracilPharmacokinetics
Date issued
2015-07-31
Language
English
Is part of
Cancer Chemotherapy and Pharmacology (2015), Vol. 76, no. 1, p. 47-52
hdl
1887/107944
doi
10.1007/s00280-015-2746-3